Prothena Corp. plc Stock
Prothena Corp. plc Stock
The price for the Prothena Corp. plc stock decreased slightly today. Compared to yesterday there is a change of -€0.200 (-1.000%).
With 13 Buy predictions and not the single Sell prediction the community is currently very high on Prothena Corp. plc.
With a target price of 80 € there is potential for a 300.0% increase which would mean more than doubling the current price of 20.0 € for Prothena Corp. plc.
Pros and Cons of Prothena Corp. plc in the next few years
Pros
?
S********** s********
?
G***** c******* t* c**********
?
M***** P*******
Cons
?
C******** o* t** e**********
?
B****
?
W********* I********* f** t** n*** y****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Prothena Corp. plc vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Prothena Corp. plc | -1.000% | -7.407% | 2.564% | -67.742% | -42.529% | 1.010% | - |
| Evolus Inc | 1.770% | -6.504% | 9.524% | 41.104% | 27.072% | 35.294% | - |
| Ardelyx Inc. | -10.570% | -13.495% | 3.702% | 103.203% | 7.578% | 9.088% | - |
| Salarius Pharmaceuticals Inc. | -4.330% | -3.398% | -6.573% | -67.377% | -28.288% | -98.367% | -99.993% |
Comments
Prothena Co. plc (NASDAQ: PRTA) had its price target lowered by analysts at HC Wainwright from $90.00 to $84.00. They now have a "buy" rating on the stock.
Show more
Ratings data for PRTA provided by MarketBeat
Prothena Co. plc (NASDAQ: PRTA) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald.
Show more
Ratings data for PRTA provided by MarketBeat
Prothena Co. plc (NASDAQ: PRTA) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $90.00 price target on the stock.
Show more
Ratings data for PRTA provided by MarketBeat